0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Choroidal Thickness and Retinal Vessel Density with Serum HIF-1α and TNF-α Level in Patients with OSAS

ORCID Icon, , , , , , & show all
Received 06 Dec 2023, Accepted 24 Jul 2024, Published online: 08 Aug 2024

References

  • Bao H, Guilleminault C. Obstructive sleep apnea syndromes. In Guilleminault C (Ed). Handbook of Clinical Neurophysiology, 2005.
  • Gabryelska A, Szmyd B, Szemraj J, Stawski R, Sochal M, Białasiewicz P. Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1α protein. J Clin Sleep Med. 2020;16(10):1761–1768. doi: 10.5664/jcsm.8682.
  • Ciccone MM, Scicchitano P, Zito A, Cortese F, Boninfante B, Falcone VA, Quaranta VN, Ventura VA, Zucano A, Di Serio F, et al. Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules. 2014;19(2):1651–1662. doi: 10.3390/molecules19021651.
  • Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P, LeJemtel TH, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117(17):2270–2278. doi: 10.1161/CIRCULATIONAHA.107.741512.
  • Santos M, Hofmann RJ. Ocular manifestations of obstructive sleep apnea. J Clin Sleep Med. 2017;13(11):1345–1348. doi: 10.5664/jcsm.6812.
  • He M, Han X, Wu H, Huang W. Choroidal thickness changes in obstructive sleep apnea syndrome: a systematic review and meta-analysis. Sleep Breath. 2016;20(1):369–378. doi: 10.1007/s11325-015-1306-8.
  • Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J. 2009;33(5):1195–1205. doi: 10.1183/09031936.00111208.
  • Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008;214(2):149–160. PMID: 18161752. doi: 10.1002/path.2287.
  • Dela Paz NG, Simeonidis S, Leo C, Rose DW, Collins T. Regulation of NF-kappaB-dependent gene expression by the POU domain transcription factor Oct-1. J Biol Chem. 2007;282(11):8424–8434. doi: 10.1074/jbc.M606923200.
  • Rimbach G, Valacchi G, Canali R, Virgili F. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun. 2000;3(4):238–242. doi: 10.1006/mcbr.2000.0219.
  • Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl). 2004;82(7):434–448. doi: 10.1007/s00109-004-0555-y.
  • Zhou J, Schmid T, Brüne B. Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol Biol Cell. 2003;14(6):2216–2225. doi: 10.1091/mbc.e02-09-0598.
  • Yu J, Xiao K, Huang J, Sun X, Jiang C. Reduced retinal vessel density in obstructive sleep apnea syndrome patients: an optical coherence tomography angiography study. Invest Ophthalmol Vis Sci. 2017;58(9):3506–3512. doi: 10.1167/iovs.17-21414.
  • Kara N, Demircan A, Karatas G, Ozgurhan EB, Tatar G, Karakucuk Y, Basci A, Demirok A. Effects of two commonly used mydriatics on choroidal thickness: direct and crossover effects. J Ocul Pharmacol Ther. 2014;30(4):366–370. doi: 10.1089/jop.2013.0093.
  • Xin C, Wang J, Zhang W, Wang L, Peng X. Retinal and choroidal thickness evaluation by SD-OCT in adults with obstructive sleep apnea-hypopnea syndrome (OSAS). Eye (Lond). 2014;28(4):415–421. doi: 10.1038/eye.2013.307.
  • Karalezli A, Eroglu FC, Kivanc T, Dogan R. Evaluation of choroidal thickness using spectral-domain optical coherence tomography in patients with severe obstructive sleep apnea syndrome: a comparative study. Int J Ophthalmol. 2014;7(6):1030–1034. doi: 10.3980/j.issn.2222-3959.2014.06.22.
  • Karaca EE, Ekici F, Yalçın NG, Çiftçi TU, Özdek Ş. Macular choroidal thickness measurements in patients with obstructive sleep apnea syndrome. Sleep Breath. 2015;9(1):335–341. doi: 10.1007/s11325-014-1025-6.
  • Zengin MÖ, Öz T, Baysak A, Çinar E, Küçükerdönmez C. Changes in choroidal thickness in patients with obstructive sleep apnea syndrome. Ophthalmic Surg Lasers Imaging Retina. 2014;45(4):298–304. doi: 10.3928/23258160-20140624-02.
  • Küçük B, Sırakaya E, Delibaş Ş. Posterior segment assessment in patients with obstructive sleep apnea syndrome. Sleep Breath. 2019;23(3):997–1005. doi: 10.1007/s11325-019-01837-z.
  • Ucak T, Unver E. Alterations in parafoveal and optic disc vessel densities in patients with obstructive sleep apnea syndrome. J Ophthalmol. 2020;2020:4034382–4034389. doi: 10.1155/2020/4034382.
  • Lin PW, Lin HC, Chang CT, Lin MC, Friedman M, Salapatas AM. Decreased peripapillary and macular vascular densities in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome. Nat Sci Sleep. 2023;15:1–12. doi: 10.2147/NSS.S384372.
  • Moyal L, Blumen-Ohana E, Blumen M, Blatrix C, Chabolle F, Nordmann JP. Parafoveal and optic disc vessel density in patients with obstructive sleep apnea syndrome: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1235–1243. doi: 10.1007/s00417-018-3943-7.
  • Cai Y, Sun GS, Zhao L, Han F, Zhao MW, Shi X. Quantitative evaluation of retinal microvascular circulation in patients with obstructive sleep apnea-hypopnea using optical coherence tomography angiography. Int Ophthalmol. 2020;40(12):3309–3321. doi: 10.1007/s10792-020-01518-x.
  • Çolak M, Özek D, Özcan KM, Eravcı FC, Karakurt SE, Karakuş MF, Evren Kemer Ö. Evaluation of retinal vessel density and foveal avascular zone measurements in patients with obstructive sleep apnea syndrome. Int Ophthalmol. 2021;41(4):1317–1325. doi: 10.1007/s10792-020-01690-0.
  • Imani MM, Sadeghi M, Khazaie H, Emami M, Sadeghi Bahmani D, Brand S. Serum and plasma tumor necrosis factor alpha levels in ındividuals with obstructive sleep apnea syndrome: a meta-analysis and meta-regression. Life (Basel). 2020;10(6):87. doi: 10.3390/life10060087.
  • Sharma H. Statistical significance or clinical significance? A researcher’s dilemma for appropriate interpretation of research results. Saudi J Anaesth. 2021;15(4):431–434. doi: 10.4103/sja.sja_158_21.
  • Liu W, Zhang W, Wang T, Wu J, Zhong X, Gao K, Liu Y, He X, Zhou Y, Wang H, et al. Obstructive sleep apnea syndrome promotes the progression of aortic dissection via a ROS-HIF-1α-MMPs associated pathway. Int J Biol Sci. 2019;15(13):2774–2782. doi: 10.7150/ijbs.34888.
  • Kothapalli CR, Ramamurthi A. Induced elastin regeneration by chronically activated smooth muscle cells for targeted aneurysm repair. Acta Biomater. 2010;6(1):170–178. doi: 10.1016/j.actbio.2009.06.006.
  • Smith ER, Tomlinson LA, Ford ML, McMahon LP, Rajkumar C, Holt SG. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension. 2012;59(5):973–978. doi: 10.1161/HYPERTENSIONAHA.111.187807.
  • Correia ML, Haynes WG. Arterial compliance and endothelial function. Curr Diab Rep. 2007;7(4):269–275. doi: 10.1007/s11892-007-0043-1.
  • Dogan Z, Ileri C, Ozben B, Sunbul M, Tigen MK, Sahin O, Yesildag O. Evaluation of arterial stiffness and subfoveal choroidal thickness in patients with coronary slow flow. Acta Cardiol Sin. 2023;39(5):733–741. doi: 10.6515/ACS.202309_39(5).20230209A.
  • Liao D, Wong TY, Klein R, Jones D, Hubbard L, Sharrett AR. Relationship between carotid artery stiffness and retinal arteriolar narrowing in healthy middle-aged persons. Stroke. 2004;35(4):837–842. doi: 10.1161/01.STR.0000120310.43457.AD.
  • Provis JM. Development of the primate retinal vasculature. Prog Retin Eye Res. 2001;20(6):799–821. doi: 10.1016/s1350-9462(01)00012-x.PMID: 11587918.
  • Snodderly DM, Weinhaus RS, Choi JC. Neural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis). J Neurosci. 1992;12(4):1169–1193. doi: 10.1523/JNEUROSCI.12-04-01169.1992.
  • Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008;31(8):1079–1085.
  • Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31(8):1071–1078.
  • McNicholas WT, Bonsigore MR, Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007;29(1):156–178. doi: 10.1183/09031936.00027406.
  • Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005;142(3):187–197. doi: 10.7326/0003-4819-142-3-200502010-00010.
  • Williams A, Scharf SM. Obstructive sleep apnea, cardiovascular disease, and inflammation–is NF-kappaB the key? Sleep Breath. 2007;11(2):69–76. doi: 10.1007/s11325-007-0106-1.
  • Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun. 2006;343(2):591–596. doi: 10.1016/j.bbrc.2006.03.015.
  • Kletsas D, Pratsinis H, Mariatos G, Zacharatos P, Gorgoulis VG. The proinflammatory phenotype of senescent cells: the p53-mediated ICAM-1 expression. Ann NY Acad Sci. 2004;1019(1):330–332. doi: 10.1196/annals.1297.056.
  • Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol. 2006;38(10):1654–1661. doi: 10.1016/j.biocel.2006.03.021.
  • Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005;112(17):2660–2667. doi: 10.1161/CIRCULATIONAHA.105.556746.
  • Ryan S, McNicholas WT, Taylor CT. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation. Biochem Biophys Res Commun. 2007;355(3):728–733. doi: 10.1016/j.bbrc.2007.02.015.
  • Luo Y, Zhang FR, Wu JL, Jiang XJ. Efficacy of continuous positive airway pressure on TNF-α in obstructive sleep apnea patients: a meta-analysis. PLoS One. 2023;18(3):e0282172. doi: 10.1371/journal.pone.0282172.
  • Liu C, Wang H, Zhu C, Wang S. Plasma expression of HIF-1α as novel biomarker for the diagnosis of obstructive sleep apnea-hypopnea syndrome. J Clin Lab Anal. 2020;34(12):e23545. doi: 10.1002/jcla.23545.
  • Naranjo-Bonilla P, Giménez-Gómez R, Muñoz-Villanueva MDC, Jurado-Gámez B. Retinal and choroidal effects of continuous positive airway pressure as treatment for sleep apnea: results at 12 months. Int J Environ Res Public Health. 2022;19(19):12637. doi: 10.3390/ijerph191912637.
  • Britton A, Schulz A, Luscombe G, Tong J, Wong B, Farah C, Graham SL, Fraser C. Retinal vessel density changes in treated and untreated obstructive sleep apnoea. Invest Ophthalmol Visual Sci. 2021;62(8):2476–2476.
  • Copete S, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno JM. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol. 2014;98(3):334–338. doi: 10.1136/bjophthalmol-2013-303904.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.